Cleveland Clinic Lerner Research Institute Logo
Cleveland Clinic Lerner Research Institute Logo
  • About
  • Science
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • Ohio
      3D Printing Bioimage AnalysisBioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering
      Flow CytometryGenomic Medicine Institute Biorepository Genomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & Administrative Engagement & Belonging
  • Donate
  • Contact
  • About
  • Science
    • Scientific Programs
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • All Cores
    • Ohio
      3D Printing Bioimage Analysis BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering >
      Flow CytometryGenomic Medicine Institute BiorepositoryGenomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Research Education & Training Center
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & AdministrativeEngagement & Belonging
  • Donate
  • Contact
  • Search

Natalie Silver Laboratory

❮Immunotherapy & Precision Immuno-Oncology Natalie Silver Laboratory
  • Natalie Silver Laboratory
  • Principal Investigator
  • Research
  • Our Team
  • Publications
  • Careers

Principal Investigator

Natalie Silver Headshot

Natalie Silver, MD, MS, FACS

Associate Staff
Associate Staff, Otolaryngology, Head & Neck Institute
Location: Cleveland Clinic Main Campus

Research

The overall goal of the Silver lab is to improve the lives of head and neck cancer patients through translational research and inspire and train the next generation of physician-scientists and scientists. Our mission is to contribute to the scientific understanding of head and neck cancer by using preclinical models and patient tissue samples, and explore novel ways to reprogram the tumor immune microenvironment for therapeutic benefit.


Biography

Dr. Silver is a head and neck surgical oncologist with a translational research lab. She treats patients at the Cleveland Clinic Head and Neck Institute and Taussig Cancer Center. View her clinical profile on the Cleveland Clinic website. She is a Principal Investigator of a lab in the Center of Immunotherapy and Precision Immuno-Oncology. She serves as the Director of Head and Neck Cancer Research.


Education & Professional Highlights

Appointed
2021

Education and Fellowships

Fellowship - University of Texas- Anderson Cancer Center
Surgical Oncology Fellow
Houston, TX USA
2016

Residency - University of Kentucky College of Medicine
ENT
Lexington, KY USA
2014

Medical Education - Georgetown University School of Medicine
Washington, DC USA
2009

Graduate - Georgetown University Graduate School of Arts and Sciences
2004

Certifications

Otolaryngology - Head and Neck Surgery

Research

Research

The overall goal of our lab is to improve the lives of head and neck cancer patients through translational research and inspire and train the next generation of physician-scientists and scientists. Our mission is to contribute to the scientific understanding of head and neck cancer by using preclinical models and patient tissue samples, and explore novel ways to reprogram the tumor immune microenvironment for therapeutic benefit.

Our main areas of research include:

  1. RNA nano-vaccines for head and neck cancer: We use preclinical models to investigate the effects of novel therapeutics on the tumor immune micro-environment. We are developing personalized therapeutic mRNA nano-vaccines for recurrent/metastatic head and neck cancer and thyroid cancer. Our lab aims to understand the anti-tumor mechanisms of these vaccines by investigating effects on immunosuppressive myeloid cells. We anticipate initiation of human clinical trials of our vaccine formulations within the next year.

  2. Comparative Oncology, feline oral cancer immunotherapy clinical trial: In order to facilitate translation from bench to bedside, in collaboration with the University of Florida College of Veterinary Medicine, we are running a clinical trial for feline pets with oral cancer. These pets have naturally or “spontaneously occurring” cancers of the oral cavity and their owners are seeking treatment for this difficult-to-treat disease. The expected lifespan is only 1-2 months after diagnosis. Our team has treated several felines with personalized RNA nano-vaccines derived from their tumors. Just like in human clinical trials, we can obtain very valuable information about the therapy including safety, efficacy and immunologic correlates.

  3. Oral microbiome and the tumor immune-microenvironment: We are investigating the role of pathogenic oral bacteria and their effects on oral cancer growth and progression via immunologic interactions. We utilize preclinical models of oral cancer and human tissue samples for our experiments. We hope to identify potential microbial targets that can be used to develop therapies for patients.

Our Team

Our Team

Publications

Selected Publications

View publications for Natalie Silver, MD, MS, FACS
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)


Selected Publications

Chieko Michikawa, Vancheswaran Gopalakrishnan, Amani M. Harrandah, Tatiana V Karpinets, Rekha Rani Garg, Randy A. Chu, Yuk Pheel Park, Sasanka S. Chukkapallia, Nikhita Yadlapalli, Kelly C. Erikson-Carter, Frederico Omar Gleber-Netto, Elias Sayour, Ann Progulske-Fox, ‏Edward K.L. Chan, Xiaogang Wu, Jianhua Zhang, Christian Jobin, Jennifer A. Wargo, Curtis R. Pickering, Jeffrey N. Myers, Natalie Silver, Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1), Neoplasia, Volume 31, 2022, 100813, ISSN 1476-5586, https://doi.org/10.1016/j.neo.2022.100813.

Careers

Careers

Please join us in our fight against head and neck cancer! If you are interested in joining our lab please contact Dr. Natalie Silver at [email protected].


Training at Lerner Research Institute

Our education and training programs offer hands-on experience at one of the nationʼs top hospitals. Travel, publish in high impact journals and collaborate with investigators to solve real-world biomedical research questions.

Learn More

Subscribe to get the latest research news in your inbox.

About Lerner

About Us Careers Contact Us Donate People Directory

Science

Clinical & Translational Research Core Services Departments, Centers & Programs Laboratories Research News

Education & Training

Graduate Programs Molecular Medicine PhD Program Postdoctoral Program RISE Program Undergraduate & High School Programs

Site Information & Policies

Search Site Site Map Privacy Policy Social Media Policy

9500 Euclid Avenue, Cleveland, Ohio 44195 | © 2025 Lerner Research Institute